Moffitt doctors present at American Society of Clinical Oncologists in Atlanta

May 23, 2006

Tampa, FL  – Six doctors from H. Lee Moffitt Cancer Center & Research Institute will present lectures and poster presentations at the 5th Annual American Society of Clinical Oncology June 2-6 in Atlanta.

Including:

Gerold Bepler, MD, PhD

Leader, Thoracic Oncology Program

Professor, Medical Oncologist

New Biology of Lung: Beyond Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor – Prognostic and Therapeutic Impact

Research Interest: Predictive molecular and cell biologic markers of lung cancer risk, progression, metastatic spread, response to treatment, and outcome

Kapil N. Bhalla, MD Scientific Director of the Malignant Hematology Program

Professor, Medical Oncologist

HSP90 as a Target for Cancer Therapeutics

Research Interest: Validation of therapeutic targets and targeted therapeutics involving heat shock proteins, histone deacetylase and oncoprotein kinases in hematologic malignancies and breast cancer

Martine Extermann, MD, PhD Associate Professor, Medical Oncologist What’s New in Geriatric Oncology: Review of Recent Evidence Research Interest: Senior adult oncology Dr. Extermann will also present an education session

What's New in Geriatric Oncology: Review of Recent Evidence

Eduardo M. Sotomayor, MD Head, Lymphoma Section, Division of Malignant Hematology and Division of Immunology

Associate Professor, Medical Oncologist

Targeting Tolerogenic Mechanisms in Cancer

Research Interest: Lymphomas; cancer vaccines; immunotherapy; immune tolerance And Dmitry I. Gabrilovich, MD, PhD Immunology Program Professor, Medical Oncology

Immunotherapy by Targeting Tumor-Mediated Immunosuppression Research Interest: Tumor Immunology and cancer vaccines

Dr. Sotomayor will also be a chair of the oral abstract session: Developmental Therapeutics: Immunotherapy

Andy Trotti, MD

Director, Radiation Oncology Clinical Research

Professor, Radiation Oncologist

Chemo radiation for Head and Neck Cancer: Patient Selection, Supportive Medical Care and Speech/Swallowing Rehabilitation

Research Interest: Radiation timing, schedule, and dose; radiation and chemotherapy safety; toxicity antagonists; head and neck cancer; melanoma

Andy Trotti MD

Discussant: Poster Session, Head and Neck Cancer

In 2001, H. Lee Moffitt Cancer Center & Research Institute earned NCI Comprehensive Cancer Center status in recognition of its excellence in research and contributions to clinical trials, prevention and cancer control. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of America’s Best Hospitals for cancer. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.

###